Smoking status and severity of SARS-CoV-2 infection in Lebanese adults: a cross-sectional study | BMC Infectious Diseases
Severe acute respiratory syndrome (SARS) [Internet]. [cited 2022 Mar 29]. Available at: https://www.who.int/westernpacific/health-topics/severe-acute-respiratory-syndrome.
Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Breath Res. 2020;21(1):224.
Bian J, Li Z. Angiotensin converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm Sin B. 2021;11(1):1–12.
Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin converting enzyme 2 (ACE2) in COVID-19. Critical care. 2020;24(1):422.
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–90.
Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3–20.
Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, et al. COVID-19: bringing down a global health crisis. Ann Clin Microbiol Antimicrobial. 2021;20(1):35.
Schlesinger S, Neuenschwander M, Lang A, Pafili K, Kuss O, Herder C, et al. Diabetes risk phenotypes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetology. 2021;64(7):1480–91.
Thakur B, Dubey P, Benitez J, Torres JP, Reddy S, Shokar N, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality in people with COVID-19. Sci Rep. 2021;20(11):8562.
Google Scholar
Semenzato L, Botton J, Drouin J, Cuenot F, Dray-Spira R, Weill A, et al. Chronic diseases, health conditions and risk of hospitalization and hospital mortality related to COVID-19 during the first wave of the epidemic in France: a cohort study of 66 million people. The Lancet Regional Health-Europe [Internet]. Sep 1, 2021 [cited 2022 Mar 29];8. Available at: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(21)00135-6/fulltext.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical features of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Cattaruzza MS, Zagà V, Gallus S, D’Argenio P, Gorini G. Smoking and the COVID-19 pandemic: old and new issues. A summary of evidence from the scientific literature. Acta Biomed. 2020;91(2):106–12.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–41.
Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and COVID-19 mortality: a rapid review of the living evidence with meta – Bayesian analyzes (version 7). Addiction. 2021;116(6):1319–68.
Vallarta-Robledo JR, Sandoval JL, Baggio S, Salamun J, Jacquérioz F, Spechbach H, et al. Negative association between smoking and positive SARS-CoV-2 screening: results from a sample of Swiss outpatients. Before Public Health. 2021;9. https://doi.org/10.3389/fpubh.2021.731981.
Prinelli F, Bianchi F, Drago G, Ruggieri S, Sojic A, Jesuthasan N, et al. Association between smoking and SARS-CoV-2 infection: a cross-sectional study of the EPICOVID19 online survey. JMIR Public Health Surveillance. 2021;7(4):e27091.
Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: a narrative review. Tob Induc Dis. 2020;14(18):60.
Google Scholar
Peng F, Lei S, Zhang Q, Zhong Y, Wu S. Smoking is correlated with the prognosis of patients with coronavirus disease 2019 (COVID-19): an observational study. Before Physiol. 2021;12:634842.
Shastri MD, Shukla SD, Chong WC, Rajendra KC, Dua K, Patel RP, et al. Smoking and COVID-19: what we know so far. Breath Med. 2021;176:106237.
Haddad C, BouMalhab S, Sacre H, Salameh P. Smoking and COVID-19: a scoping review. Use Insights. 2021;14:1179173X21994612.
Zamorano Cuervo N, Grandvaux N. ACE2: Evidence for the role as an entry receptor for SARS-CoV-2 and implications in comorbidities. Elife. 2021;9:e61390.
Google Scholar
Gadanec LK, McSweeney KR, Qaradakhi T, Ali B, Zulli A, Apostolopoulos V. Can the SARS-CoV-2 virus use multiple receptors to enter host cells? Int J Mol Sci. 2021;22(3):992.
Dormoy V, Perotin JM, Gosset P, Maskos U, Polette M, Deslée G. Nicotinic receptors as spike co-receptors of SARS-CoV-2? Medical assumptions. 2022;158:110741.
Duszynski TJ, Fadel W, Wools-Kaloustian KK, Dixon BE, Yiannoutsos C, Halverson PK, et al. Association of health status and nicotine use with SARS-CoV-2 positivity rates. BMC Public Health. 2021;3(21):1786.
Google Scholar
Ismail N, Hassan N, Abd Hamid MHN, Yusoff UN, Khamal NR, Omar MA, et al. Association of smoking and severity of COVID-19 infection in 5889 patients in Malaysia: a multicenter observational study. Int J Infect Dis. 2022;1(116):189–96.
Google Scholar
He Y, Sun J, Ding X, Wang Q. Mechanisms in which smoking increases the risk of COVID-19 infection: a narrative review. Iran J Public Health. 2021;50(3):431–7.
Wark PAB, Pathinayake PS, Kaiko G, Nichol K, Ali A, Chen L, et al. ACE2 expression is elevated in airway epithelial cells of healthy elderly and male individuals, but reduced in asthma. Pneumology. 2021. https://doi.org/10.1111/resp.14003.
Smith JC, Sausville EL, Girish V, Yuan ML, Vasudevan A, John KM, et al. Cigarette smoke exposure and inflammatory signaling increase SARS-CoV-2 ACE2 receptor expression in the airways. Development cell. 2020;53(5):514-529.e3.
Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;20(18):20.
Google Scholar
Abdulrahim S, Jawad M. Socioeconomic differences in smoking in Jordan, Lebanon, Syria and Palestine: a cross-sectional analysis of national surveys. PLOS ONE. 2018;13(1):e0189829.
Prevalence of current tobacco use (% of adults) – Lebanon | Data [Internet]. [cited 2022 Apr 6]. Available at: https://data.worldbank.org/indicator/SH.PRV.SMOK?locations=LB.
Nakkash R, Khader Y, Chalak A, Abla R, Abu-Rmeileh NME, Mostafa A, et al. Smoking prevalence among adults in three eastern Mediterranean countries: a cross-sectional household survey. BMJ open. 2022;12(3):e055201.
Khalil A, Dhingra R, Al-Mulki J, Hassoun M, Alexis N. Interrogating sex-specific differences in the association of smoking with the survival rate of hospitalized COVID-19 patients. PLOS ONE. 2021;16(8):e0255692.
Baddoura R, Wehbeh-Chidiac C. Prevalence of smoking among the adult Lebanese population. Eastern Mediterranean Health J. 2001;7(4–5):819–28.
Central Administration of Statistics-Population [Internet]. [cited 2021 Nov 10]. Available at: http://www.cas.gov.lb/index.php/demographic-and-social-en/population-en.
Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male gender identified by global COVID-19 meta-analysis as a risk factor for death and admission to ITU. Common Nat. 2020;11(1):6317.
Capuano A, Rossi F, Paolisso G. COVID-19 kills more men than women: an overview of possible reasons. Before Cardiovascular Med. 2020;17(7):131.
Google Scholar
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Before Public Health. 2020. https://doi.org/10.3389/fpubh.2020.00152.
Townsend EA, Miller VM, Prakash YS. Gender differences and sex steroids in lung health and disease. Endocr Rev. 2012;33(1):1–47.
Camp PG, Coxson HO, Levy RD, Pillai SG, Anderson W, Vestbo J, et al. Gender differences in emphysema and airway disease in smokers. Chest. 2009;136(6):1480–8.
Haghani A, Arpawong TE, Kim JK, Lewinger JP, Finch CE, Crimmins E. Female vulnerability to health effects of smoking in older adults. PLOS ONE. 2020;15(6):e0234015.
Das AB. The Lung Disease Network reveals the impact of comorbidity on SARS-CoV-2 infection and opportunities for drug reuse. BMC Med Genomics. 2021;17(14):226.
Google Scholar
Lallai V, Manca L, Fowler CD. E-cigarette vaping and pulmonary ACE2 expression: implications for coronavirus vulnerability. About Toxicol Pharmacol. 2021;1(86):103656.
Google Scholar
WHO statement: Tobacco use and COVID-19 [Internet]. [cited 2022 Apr 6]. Available at: https://www.who.int/news/item/11-05-2020-who-statement-tobacco-use-and-covid-19.
